180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (NASDAQ: ATNF) on December 2, 2024, covering events occurring on December 2 and December 3, 2024. The filing addresses changes to the composition of the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial disclosure relates to director compensation: the newly appointed director, Stephen H. Shoemaker, will receive an annual retainer fee of $50,000, payable quarterly in arrears, with an option to receive half in cash and half in stock.
Material Changes
- Resignation of Director: Omar Jimenez resigned from the Board of Directors effective December 3, 2024. His resignation was not due to a disagreement with the company but to facilitate the appointment of a new director. Mr. Jimenez continues to serve as Chief Financial Officer and Secretary.
- Appointment of New Director: Stephen H. Shoemaker was appointed to the Board effective December 3, 2024, as a Class I director serving until the 2025 Annual Meeting. He was immediately appointed to the Audit Committee.
- Committee Composition: The Board now consists of a majority of independent members. The Audit Committee now comprises three members (Lawrence Steinman, Jay Goodman, and Stephen H. Shoemaker).
Outlook, Risks, and Management Commentary
Management states that the appointment of Mr. Shoemaker, who is deemed independent, allows the company to regain compliance with Nasdaq Listing Rule 5605(c)(2), which requires an audit committee of at least three independent directors. Mr. Shoemaker brings extensive experience in capital markets, mergers and acquisitions, and the iGaming sector, having previously served as CEO of WIN Group and Engine Media Holdings, Inc.
Investor Verification Checklist
- Verify the independence status of the new Audit Committee members to ensure ongoing Nasdaq compliance.
- Review the attached Offer Letter (Exhibit 10.1) for full details on Mr. Shoemaker's compensation and service terms.
- Confirm the continued role of Omar Jimenez as CFO and the impact of his departure from the Board on financial oversight.
- Check for any subsequent filings regarding the 2025 Annual Meeting to confirm the election status of the new director.